1526
physiological variations, short half-lives, effects’ of coagulation activation peptides.
Number of fatal and non-fatal atherothrombotic events, as fifths of mean basal, and 12-month antithrombin III distribution.
the PLAT study (ref 1, and Cortellaro M, Boschetti C, Cofrancesco et al, unpublished). Antithrombin III was measured by a chromogenic method, and mean basal and 12-month values were calculated. Our data (figure) showed no appreciable difference in number of events in antithrombin III distribution in fifths, although there was a trend to a reduction of these events from the lowest to the highest fifth. With respect to Meade and colleagues’ unexpected finding that "antithrombin III levels were directly correlated with high rather than low levels of factor VII activity and of plasma fibrinogen", we have shown that antithrombin III correlated directly not only with plasma fibrinogen (r=0271, p
physiological variations, short half-lives, effects’ of coagulation activation peptides.
Number of fatal and non-fatal atherothrombotic events, as fifths of mean basal, and 12-month antithrombin III distribution.
the PLAT study (ref 1, and Cortellaro M, Boschetti C, Cofrancesco et al, unpublished). Antithrombin III was measured by a chromogenic method, and mean basal and 12-month values were calculated. Our data (figure) showed no appreciable difference in number of events in antithrombin III distribution in fifths, although there was a trend to a reduction of these events from the lowest to the highest fifth. With respect to Meade and colleagues’ unexpected finding that "antithrombin III levels were directly correlated with high rather than low levels of factor VII activity and of plasma fibrinogen", we have shown that antithrombin III correlated directly not only with plasma fibrinogen (r=0271, p
